Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea 

Eli Lilly said Friday that it has applied for U.S. regulatory approval to expand the use of its weight-loss drug Zepbound to include treatment of sleep apnea, as new data show the drug may help many people breathe easier at night.

For more details: Read More